Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02869893 · ClinicalTrials.gov registry record · NA
MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT02869893 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 57 participants.
The verdict
NCT02869893, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
The goal of this research study is to learn more about the pancreas. The investigators want to use Magnetic Resonance Cholangiopancreatography (MRCP) to learn more about the size of a normal pancreas. MRCP is a special kind of MRI exam that produces detailed images of the pancreas. The investigators also want to figure out how much fluid the pancreas releases in response to secretin. Secretin is a chemical in the body that causes the pancreas to release fluid that helps with digestion. Secretin is used during the MRCP (MR-PFT) to help identify dysfunction of the pancreas. MR elastography (MRE) will be used to measure how hard the pancreas is. MRE is a special kind of MRI that uses vibrations to image tissue.
Interventions
- DRUG Secretin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-08-10 |
| Est. Completion | 2017-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02869893
The ClinicalTrials.gov registry entry for NCT02869893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Secretin is the first listed.
NCT02869893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02869893 about?
NCT02869893 is a clinical study titled "MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics". The goal of this research study is to learn more about the pancreas. The investigators want to use Magnetic Resonance Cholangiopancreatography (MRCP) to learn more about the size of a normal pancreas. MRCP is a special kind of MRI exam that produces detailed images of the pancreas. The investigators...
What is the current status of trial NCT02869893?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2016-08-10. Estimated completion is 2017-04-06.
What interventions are being tested in trial NCT02869893?
The interventions under investigation include: Secretin (DRUG).
Who is sponsoring clinical trial NCT02869893?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.